Praised for having the ‘highest level of ambition’, the team at A&O Shearman leverages its network of offices across Europe to advise its varied client base of medtech and biotech companies as well as financial institutions. IP litigator Frits Gerritzen and Christiaan De Brauw jointly head the practice. Gerritzen is known for his vast knowledge of patent enforcement actions and the validity of IP rights, particularly in relation to medical equipment and antibodies, while de Brauw has vast transactional expertise, advising pharma and biotech clients on IPOs, public takeovers, and public M&A. Leading the firm’s investment management practice, Ellen Cramer de Jong advises investors on regulatory and corporate issues.
Testimonials
Collated independently by Legal 500 research team.
‘Frits Gerritzen has a wealth of experience in pan-European life sciences patent litigations. He is supported by associate Sophie van Asten.’
‘Frits Gerritzen leads the life sciences team in the Netherlands. Frits is diligent and shown some in-depth knowledge in genetic engineering and immunology. He gets very involved in the matters, which is great from a client perspective.’
Key clients
- Life Sciences Partners
- Xinvento